ɬ﷬

Call for Applications: D2R Award in Genomic Medicine and Indigenous Health

Published: 30 July 2025

To mark the 25th anniversary of Génome Québec, ɬ﷬’s DNA to RNA (D2R) Initiative is launching a special call for applications for the D2R Award in Genomic Medicine and Indigenous...

Expanding access to specialized healthcare across Quebec: ECHO Superhub at The Neuro

Published: 25 March 2025

Free, online training program strengthens training and brings specialized care to communities across Quebec...

Project to create AI model for ALS receives Génome Québec funding

Published: 17 March 2025

$400,000 will fuel public-private collaboration to discover new disease biomarkers...

Genetic sequencing project receives more than $8 million in funding

Published: 18 March 2025

NeuRo Genomics Initiative will help better understand rare and aging-related neurological disorders affecting Canadians...

Prescribing anti-swelling drug reduces immune response weeks after last dose

Published: 26 February 2025

Mapping immune cell diversity reveals dexamethasone’s impact on brain cancer immunotherapy...

AI analysis of healthcare records reveals key factors in autism diagnosis

Published: 26 March 2025

Scientists argue the criteria we use for diagnosing autism may need revision...

Latest Alzheimer’s drug shown less effective in females than males

Published: 18 March 2025

Since becoming only the second Alzheimer’s-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD...

Six principal investigators from The Neuro receive CIHR grants

Published: 10 February 2025

Projects include important research on Parkinson’s, glioblastoma and dementia  

Pages

Back to top